149 related articles for article (PubMed ID: 29362353)
1. Role of Xeroderma Pigmentosum Group D in Cell Cycle and Apoptosis in Cutaneous Squamous Cell Carcinoma A431 Cells.
Liu OG; Xiong XY; Li CM; Zhou XS; Li SS
Med Sci Monit; 2018 Jan; 24():453-460. PubMed ID: 29362353
[TBL] [Abstract][Full Text] [Related]
2. [Mechanism of regulation of hepatoma cell cycle by XPD/P44 subcomplex : an in vitro experiment].
Wang HY; Xiong GF; Wu BL; Zhang JX
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1997-2001. PubMed ID: 19062744
[TBL] [Abstract][Full Text] [Related]
3. Silencing of Xeroderma Pigmentosum Group D Gene Promotes Hepatoma Cell Growth by Reducing P53 Expression.
Ding H; Wen Z; Sun G
Med Sci Monit; 2018 Nov; 24():8015-8021. PubMed ID: 30409962
[TBL] [Abstract][Full Text] [Related]
4. Xeroderma Pigmentosum Group D (XPD) Inhibits the Proliferation Cycle of Vascular Smooth Muscle Cell (VSMC) by Activating Glycogen Synthase Kinase 3β (GSK3β).
Li Q; Liao C; Xu W; Li G; Hong K; Cheng X; Li J
Med Sci Monit; 2018 Aug; 24():5951-5959. PubMed ID: 30146633
[TBL] [Abstract][Full Text] [Related]
5. Fibulin-3 Has Anti-Tumorigenic Activities in Cutaneous Squamous Cell Carcinoma.
Wang X; Zhang Q; Li C; Qu X; Yang P; Jia J; Song L; Fan W; Jing H; Zheng Y
J Invest Dermatol; 2019 Aug; 139(8):1798-1808.e5. PubMed ID: 30738056
[TBL] [Abstract][Full Text] [Related]
6. Yes-Associated Protein Contributes to the Development of Human Cutaneous Squamous Cell Carcinoma via Activation of RAS.
Jia J; Li C; Luo S; Liu-Smith F; Yang J; Wang X; Wang N; Lai B; Lei T; Wang Q; Xiao S; Shao Y; Zheng Y
J Invest Dermatol; 2016 Jun; 136(6):1267-1277. PubMed ID: 26902922
[TBL] [Abstract][Full Text] [Related]
7. miR-497 promotes the progression of cutaneous squamous cell carcinoma through FAM114A2.
Wei XH; Gu XL; Zhou XT; Ma M; Lou CX
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7348-7355. PubMed ID: 30468480
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressor in lung cancer 1 (TSLC1), a novel tumor suppressor gene, is implicated in the regulation of proliferation, invasion, cell cycle, apoptosis, and tumorigenicity in cutaneous squamous cell carcinoma.
Liu D; Feng X; Wu X; Li Z; Wang W; Tao Y; Xia Y
Tumour Biol; 2013 Dec; 34(6):3773-83. PubMed ID: 23812766
[TBL] [Abstract][Full Text] [Related]
9. Effects of XPD mutations on ultraviolet-induced apoptosis in relation to skin cancer-proneness in repair-deficient syndromes.
Queille S; Drougard C; Sarasin A; Daya-Grosjean L
J Invest Dermatol; 2001 Nov; 117(5):1162-70. PubMed ID: 11710928
[TBL] [Abstract][Full Text] [Related]
10. Expression analysis and biological regulation of silencing regulatory protein 6 (SIRT6) in cutaneous squamous cell carcinoma.
Chen S; Chen H; Wang X; Zhang D; Zhang L; Cheng J; Zhang Q; Hua Z; Miao X; Shi J
An Bras Dermatol; 2024; 99(4):535-545. PubMed ID: 38548549
[TBL] [Abstract][Full Text] [Related]
11. Maspin suppresses growth, proliferation and invasion in cutaneous squamous cell carcinoma cells.
Zhu H; Mao Q; Liu W; Yang Z; Jian X; Qu L; He C
Oncol Rep; 2017 May; 37(5):2875-2882. PubMed ID: 28405681
[TBL] [Abstract][Full Text] [Related]
12. Bromodomain protein BRD4 promotes cell proliferation in skin squamous cell carcinoma.
Xiang T; Bai JY; She C; Yu DJ; Zhou XZ; Zhao TL
Cell Signal; 2018 Jan; 42():106-113. PubMed ID: 29050985
[TBL] [Abstract][Full Text] [Related]
13. An Xpd mouse model for the combined xeroderma pigmentosum/Cockayne syndrome exhibiting both cancer predisposition and segmental progeria.
Andressoo JO; Mitchell JR; de Wit J; Hoogstraten D; Volker M; Toussaint W; Speksnijder E; Beems RB; van Steeg H; Jans J; de Zeeuw CI; Jaspers NG; Raams A; Lehmann AR; Vermeulen W; Hoeijmakers JH; van der Horst GT
Cancer Cell; 2006 Aug; 10(2):121-32. PubMed ID: 16904611
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-203 Inversely Correlates with Differentiation Grade, Targets c-MYC, and Functions as a Tumor Suppressor in cSCC.
Lohcharoenkal W; Harada M; Lovén J; Meisgen F; Landén NX; Zhang L; Lapins J; Mahapatra KD; Shi H; Nissinen L; Kähäri VM; Ståhle M; Sonkoly E; Grandér D; Arsenian-Henriksson M; Pivarcsi A
J Invest Dermatol; 2016 Dec; 136(12):2485-2494. PubMed ID: 27452220
[TBL] [Abstract][Full Text] [Related]
15. ERCC2/XPD Lys751Gln alter DNA repair efficiency of platinum-induced DNA damage through P53 pathway.
Zhang G; Guan Y; Zhao Y; van der Straaten T; Xiao S; Xue P; Zhu G; Liu Q; Cai Y; Jin C; Yang J; Wu S; Lu X
Chem Biol Interact; 2017 Feb; 263():55-65. PubMed ID: 28027876
[TBL] [Abstract][Full Text] [Related]
16. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.
Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Kivisaari A; Kallajoki M; Grénman R; Peltonen J; Peltonen S; Quint KD; Bavinck JNB; Kähäri VM
Oncotarget; 2017 Jul; 8(28):45825-45836. PubMed ID: 28526809
[TBL] [Abstract][Full Text] [Related]
17. Proline-rich 11 (PRR11) promotes the progression of cutaneous squamous cell carcinoma by activating the EGFR signaling pathway.
Wang S; Zhang X; Lei H; Song L; Huang Y; Kang T; Zhang M; Wang N; Yang P; Feng S; Wang J; Bai R; Wang N; Wang W; Zheng Y
Mol Carcinog; 2023 May; 62(5):613-627. PubMed ID: 36727626
[TBL] [Abstract][Full Text] [Related]
18. Effects of neuroblastoma breakpoint family member 1 (NBPF1) gene on growth and Akt-p53-Cyclin D pathway in cutaneous squamous carcinoma cells.
Gao Y; Zhu H; Mao Q
Neoplasma; 2019 Jul; 66(4):584-592. PubMed ID: 31058534
[TBL] [Abstract][Full Text] [Related]
19. lncRNA TINCR participates in ALA-PDT-induced apoptosis and autophagy in cutaneous squamous cell carcinoma.
Zhou W; Zhang S; Li J; Li Z; Wang Y; Li X
J Cell Biochem; 2019 Aug; 120(8):13893-13902. PubMed ID: 30993776
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of skin squamous cell carcinoma proliferation and promote apoptosis by dual silencing of NET-1 and survivin.
Ji ZJ; Wang JL; Chen L
Oncol Rep; 2015 Aug; 34(2):811-22. PubMed ID: 26080853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]